Tesamorelin - Research Grade

Tesamorelin

Informative Description:  Tesamorelin is a synthetic 44-amino-acid peptide that acts as an analog of the endogenous Growth Hormone Releasing Hormone (GHRH). It features a distinct structural modification—a hexenoyl moiety attached to its N-terminal anchor—which grants it enhanced stability and resistance against enzymatic degradation by dipeptidyl peptidase-4 (DPP-4), extending its half-life and efficacy compared to natural GHRH.
Peptide Function:
 Highly Selective GH Secretion: Binds specifically to receptors in the anterior pituitary gland to stimulate the synthesis and pulsatile release of endogenous growth hormone.
 Visceral Adipose Tissue (VAT) Modulation: Intervenes directly in lipolysis, regulating key enzymes to break down deep, metabolically active fat deposits selectively.
 Homeostatic Control: Promotes a stable increase in insulin-like growth factor 1 (IGF-1) levels without drastically altering blood glucose parameters or short-term insulin sensitivity.
Primary Uses (Research Applications):
 Lipodistrophy & Visceral Abdominal Fat Studies: Heavily researched in medical science for its unique capability to significantly reduce deep visceral adipose tissue (abdominal fat), which is strongly linked to cardiovascular risks.
 Metabolic Optimization Research: Utilized in laboratory protocols to analyze improvements in overall lipid profiles, reduction of non-HDL cholesterol, and the broader impact of growth hormone on body composition.
 Cognition & Neuroprotection Models: Evaluated in clinical and emerging scientific studies for its potential to improve cognitive functions and brain health in aging populations via the modulation of the GH/IGF-1 axis.

IMPORTANT NOTICE
FOR RESEARCH USE ONLY.
NOT FOR HUMAN OR VETERINARY CONSUMPTION.

This product is not intended to diagnose, treat, cure, or prevent any disease.